During the past decade, Klinika Ambroziak Dermatologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinika Ambroziak Dermatologia" are "Plaque Psoriasis" (2 trials). Many other conditions were trialed in "Klinika Ambroziak Dermatologia" in a lesser frequency.

Most popular intervention types in "Klinika Ambroziak Dermatologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ABP 501" (1 trials), "ABP 654" (1 trials), "Adalimumab" (1 trials) and "Ustekinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinika Ambroziak Dermatologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinika Ambroziak Dermatologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinika Ambroziak Dermatologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinika Ambroziak Dermatologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".